about
Induction and localization of cutaneous interleukin-1 beta mRNA during contact sensitizationAcute stress modulates the irritant component of sensitizers in allergic contact dermatitis: implications for exposure assessment.C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivityProteomic analysis of laser microdissected melanoma cells from skin organ cultures.Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.The relationship between race, inflammation and psychosocial factors among pregnant women.Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts.Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase.Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis.Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway.Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones.Proteomic analysis of the murine liver in response to a combined exposure to psychological stress and 7,12-dimethylbenz(a)anthracene.Differential regulation of sensitizer-induced inflammation and immunity by acute restraint stress in allergic contact dermatitis.Genomic profiling of restraint stress-induced alterations in mouse T lymphocytes.Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton.PRODUCTION AND IN SITU LOCALIZATION OF CUTANEOUS TUMOUR NECROSIS FACTOR α (TNF-α) AND INTERLEUKIN 6 (IL-6) FOLLOWING SKIN SENSITIZATIONStress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase
P50
Q23912804-BBCB25B5-F18B-4948-B144-F4641ACB6064Q23918160-EEA1AAC1-4B3F-42DA-A9DA-B4CAE20FC68BQ23918163-21D220D7-C0E1-4018-BEAB-B1F6C0F78987Q33574736-DB09B078-78FE-4267-AB3B-87D98F0C7932Q33924908-60E1D5ED-8CB7-46C8-A0FA-163DA005F8ABQ34642161-3C2DE2CF-D529-4C8D-9413-16160F546FEEQ36839408-C821EDD6-568B-4095-AAA2-1B19C5F02997Q39672234-90751638-EF87-41A9-A7E6-7DFF5579633DQ39697484-A9C6BC3F-7506-420B-951C-BC76AB59AA7BQ39832274-E67D07A2-CE22-475C-B684-DE377FD20A3CQ40981383-F1F0600B-3FEF-44F8-88A2-11E870428FD7Q42828900-DDCF259D-45DC-433B-9F61-FDA836E900DAQ43235617-55D0FA20-49FA-417D-8E6C-2711C0F4285EQ44514292-2335F259-655A-41AB-AEB2-7EB477A2F3EDQ46606543-98532D88-AE0C-42A9-8981-73A9ADBA366AQ53259685-FF956AD3-F1F9-431E-A93A-D70F9920D507Q61865249-CBE8D80B-C2BA-4A33-B6F6-10420CB7189AQ92317013-F257706B-21BC-47D0-B51F-3760435A70AB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Melanie S Flint
@nl
Melanie S Flint
@sl
Melanie S. Flint
@en
Melanie S. Flint
@es
type
label
Melanie S Flint
@nl
Melanie S Flint
@sl
Melanie S. Flint
@en
Melanie S. Flint
@es
prefLabel
Melanie S Flint
@nl
Melanie S Flint
@sl
Melanie S. Flint
@en
Melanie S. Flint
@es
P108
P106
P1153
7004358506
P21
P31
P496
0000-0001-5311-3023